Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom. --FAKE GBP drops as BOE vote split seems dovishThe BOE has left rates unchanged in December but a more dovish vote split has weighed on the pound.
13:15, 19 December 2024
A hawkish Fed cut sparks fresh volatilityDiscover how the Federal Reserve's hawkish stance, revised SEP, and delayed inflation targets triggered market volatility, with stocks tumbling, bond yields surging, and a stronger US Dollar reshaping investor outlooks.
12:55, 19 December 2024
Gold Latest: XAU/USD stuck within range ahead of the FOMC meetingGold traders await the FOMC meeting to determine how many rate cuts to expect in 2025.
11:28, 18 December 2024
GBP/USD in focus ahead of FED and BOE meetings Both the Federal Reserve and Bank of England will deliver their updated monetary policies this week, with GBP/USD likely to experience increased momentum.
17:35, 17 December 2024